Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Down 38.3% in October

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) saw a significant decline in short interest in October. As of October 15th, there was short interest totalling 15,750,000 shares, a decline of 38.3% from the September 30th total of 25,510,000 shares. Based on an average trading volume of 9,240,000 shares, the short-interest ratio is currently 1.7 days.

Wall Street Analyst Weigh In

Separately, UBS Group started coverage on Clover Health Investments in a research report on Monday, October 7th. They issued a "neutral" rating and a $4.00 target price for the company.

Institutional Investors Weigh In On Clover Health Investments

Large investors have recently modified their holdings of the stock. Bleakley Financial Group LLC grew its stake in shares of Clover Health Investments by 98.9% in the 3rd quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company's stock worth $57,000 after buying an additional 9,988 shares during the last quarter. SignalPoint Asset Management LLC lifted its stake in shares of Clover Health Investments by 8.1% in the 3rd quarter. SignalPoint Asset Management LLC now owns 150,684 shares of the company's stock worth $425,000 after purchasing an additional 11,318 shares during the period. Jaffetilchin Investment Partners LLC raised its holdings in Clover Health Investments by 30.2% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company's stock worth $39,000 after purchasing an additional 11,550 shares during the period. Vanguard Personalized Indexing Management LLC boosted its position in shares of Clover Health Investments by 54.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company's stock worth $42,000 after purchasing an additional 12,104 shares during the period. Finally, Viewpoint Capital Management LLC boosted its stake in Clover Health Investments by 96.8% in the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company's stock worth $38,000 after purchasing an additional 15,000 shares during the period. Institutional investors own 19.77% of the company's stock.

Clover Health Investments Price Performance

NASDAQ CLOV traded up $0.13 on Friday, reaching $3.92. 3,948,972 shares of the company's stock traded hands, compared to its average volume of 9,476,254. The stock has a market cap of $1.95 billion, a PE ratio of -14.52 and a beta of 2.13. Clover Health Investments has a 12 month low of $0.61 and a 12 month high of $4.71. The stock has a 50-day simple moving average of $3.29 and a 200 day simple moving average of $1.94.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.05. The business had revenue of $356.26 million for the quarter, compared to analyst estimates of $338.70 million. Clover Health Investments had a negative return on equity of 36.55% and a negative net margin of 7.30%. During the same period last year, the company earned ($0.06) EPS. As a group, analysts anticipate that Clover Health Investments will post -0.13 EPS for the current year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.